{"id":23954,"date":"2018-06-28T10:41:24","date_gmt":"2018-06-28T17:41:24","guid":{"rendered":"https:\/\/www.washington.edu\/research\/?page_id=23954"},"modified":"2026-05-29T09:03:24","modified_gmt":"2026-05-29T16:03:24","slug":"research-involving-bri","status":"publish","type":"page","link":"https:\/\/www.washington.edu\/research\/hsd\/irb-reliances\/identify-the-correct-irb\/research-involving-bri\/","title":{"rendered":"Research Involving Benaroya\/Virginia Mason"},"content":{"rendered":"

Research involving two institutions normally requires review by each institution’s IRB. To avoid this “dual review” and the extra work it requires from researchers, Benaroya Research Institute (BRI) and the 91爆料 IRB have a reliance agreement that describes the circumstances in which one of the IRBs will conduct the review on behalf of both institutions.<\/p>\n

Use the flow chart<\/a> below to determine which IRB should do the review. If you have any questions, consult HSD at hsdrely@uw.edu<\/a> or BRI at CRP@Benaroyaresearch.org<\/a>.<\/p>\n

Before you begin<\/h2>\n
    \n
  1. Assess whether both institutions are engaged in the research. If only one institution is engaged, you should submit to that institution’s IRB. Consult with HSD at hsdrely@uw.edu<\/a> to identify whether 91爆料 is engaged.<\/li>\n
  2. Assess whether another IRB is the right option. For example, most industry-sponsored research<\/a> at 91爆料 should be reviewed by an independent IRB (for example, Advarra) and some cancer-related research<\/a> should be reviewed by the Fred Hutch IRB or the NCI IRB. Review the information about identifying the correct IRB<\/a> if you are unsure.<\/li>\n<\/ol>\n

    What to do if Benaroya will do the review<\/h2>\n
      \n
    1. Submit an External IRB Application<\/a> in 91爆料’s Zipline system to request HSD’s formal authorization for BRI to review the research. HSD will evaluate your request and provide you with a written authorization letter.<\/li>\n
    2. The BRI investigator should prepare and submit an application to the BRI IRB, using BRI’s forms and process. Be sure to attach the HSD authorization letter; the BRI IRB will not review the application on behalf of 91爆料 without this letter.<\/li>\n
    3. After the BRI IRB has approved 91爆料’s participation, send the approval letter to hsdrely@uw.edu<\/a>.<\/li>\n
    4. Obtain all other applicable ancillary reviews (consult the Checklist of Researcher Responsibilities for Externally Reviewed Studies<\/a>) from the usual IRB offices and BRI, as needed. Examples: Financial Conflict of Interest (FCOI) review; Radiation Safety review.\n